- Home
- EDUC vs CYCN Comparison
EDUC vs CYCN Comparison
Compare EDUC & CYCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDUC
- CYCN
- Stock Information
- Founded
- EDUC 1965
- CYCN 2018
- Country
- EDUC United States
- CYCN United States
- Employees
- EDUC N/A
- CYCN N/A
- Industry
- EDUC Consumer Specialties
- CYCN Biotechnology: Pharmaceutical Preparations
- Sector
- EDUC Consumer Discretionary
- CYCN Health Care
- Exchange
- EDUC Nasdaq
- CYCN Nasdaq
- Market Cap
- EDUC 11.4M
- CYCN 11.8M
- IPO Year
- EDUC N/A
- CYCN N/A
- Fundamental
- Price
- EDUC $1.30
- CYCN $2.59
- Analyst Decision
- EDUC
- CYCN
- Analyst Count
- EDUC 0
- CYCN 0
- Target Price
- EDUC N/A
- CYCN N/A
- AVG Volume (30 Days)
- EDUC 8.5K
- CYCN 57.6K
- Earning Date
- EDUC 07-07-2025
- CYCN 08-11-2025
- Dividend Yield
- EDUC N/A
- CYCN N/A
- EPS Growth
- EDUC N/A
- CYCN N/A
- EPS
- EDUC N/A
- CYCN N/A
- Revenue
- EDUC $31,304,000.00
- CYCN $2,081,000.00
- Revenue This Year
- EDUC N/A
- CYCN N/A
- Revenue Next Year
- EDUC N/A
- CYCN N/A
- P/E Ratio
- EDUC N/A
- CYCN N/A
- Revenue Growth
- EDUC N/A
- CYCN N/A
- 52 Week Low
- EDUC $0.92
- CYCN $1.27
- 52 Week High
- EDUC $2.49
- CYCN $9.47
- Technical
- Relative Strength Index (RSI)
- EDUC 45.48
- CYCN 37.25
- Support Level
- EDUC $1.30
- CYCN $2.51
- Resistance Level
- EDUC $1.40
- CYCN $2.95
- Average True Range (ATR)
- EDUC 0.05
- CYCN 0.33
- MACD
- EDUC 0.00
- CYCN -0.07
- Stochastic Oscillator
- EDUC 28.64
- CYCN 7.03
About EDUC Educational Development Corporation
Educational Development Corp is the United States trade publisher of the line of educational children's books produced in the United Kingdom. Its business activity functions with two reportable segments: PaperPie and Publishing. The Publishing Division segment markets its products to retail accounts, which include books, school supplies, toy and gift stores and museums, through commissioned sales representatives, trade and specialty wholesalers and an internal telesales group.
About CYCN Cyclerion Therapeutics Inc.
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.